These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 323834)

  • 81. Effect of xipamide in oedema of renal disease with varying degrees of renal insufficiency: a comparative trial with frusemide.
    Mihindukulasuriya J; Lee HA
    Curr Med Res Opin; 1982; 8(3):208-14. PubMed ID: 6751705
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.
    Perez J; Sitar DS; Ogilvie RI
    Br J Clin Pharmacol; 1980 May; 9(5):471-8. PubMed ID: 7397063
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Paradoxical potassium excretion in response to aldosterone antagonists.
    Ramsay LE; Harrison IR; Shelton JR; Tidd MJ
    Eur J Clin Pharmacol; 1977 Jan; 11(2):101-5. PubMed ID: 837961
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Multiple measurements of the urinary sodium-to-potassium ratio strongly related home hypertension: TMM Cohort Study.
    Kogure M; Hirata T; Nakaya N; Tsuchiya N; Nakamura T; Narita A; Miyagawa K; Koshimizu H; Obara T; Metoki H; Uruno A; Kikuya M; Sugawara J; Kuriyama S; Tsuji I; Kure S; Hozawa A
    Hypertens Res; 2020 Jan; 43(1):62-71. PubMed ID: 31562419
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dose-response relationships for spironolactone at steady state.
    McInnes GT; Perkins RM; Shelton JR; Harrison IR
    Clin Pharmacol Ther; 1982 Mar; 31(3):317-23. PubMed ID: 7060315
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical use of high doses of furosemide (Lasix) in the treatment of resistant nephrotic edema.
    Silverberg DS; Kjellstrand CM
    Acta Med Scand; 1968 Dec; 184(6):473-9. PubMed ID: 4885080
    [No Abstract]   [Full Text] [Related]  

  • 87. On the nature of the urinary volume response to diuretic agents by patients with edema.
    Gold H; Young E; Kwit NT; Golfinos AJ; Mehta D; Messeloff CR; Goessel E
    J Clin Pharmacol J New Drugs; 1968; 8(3):141-53. PubMed ID: 4872078
    [No Abstract]   [Full Text] [Related]  

  • 88. [On the modification of animal experimental retention edema by furosemide].
    Kösters S; Lüllmann H
    Klin Wochenschr; 1966 Dec; 44(24):1403-5. PubMed ID: 5994689
    [No Abstract]   [Full Text] [Related]  

  • 89. Antialdosterones: incidence and prevention of sexual side effects.
    de Gasparo M; Whitebread SE; Preiswerk G; Jeunemaître X; Corvol P; Ménard J
    J Steroid Biochem; 1989 Jan; 32(1B):223-7. PubMed ID: 2913412
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Treatment of cerebral oedema with high doses of furosemide (author's transl)].
    Thilman J; Zeumer H
    Dtsch Med Wochenschr; 1974 May; 99(18):932-5. PubMed ID: 4835539
    [No Abstract]   [Full Text] [Related]  

  • 91. [Joint study on the effectiveness of diuretic measures in hydropic diseases. IV. Statistical analysis of the relationship of the data collected].
    Horbach L; Michaelis J; Kaufmann W; Dürr F; Neuhaus GA; Praetorius F
    Klin Wochenschr; 1971 Sep; 49(18):1014-21. PubMed ID: 5093467
    [No Abstract]   [Full Text] [Related]  

  • 92. Kinetics and dynamics of furosemide and slow-acting furosemide.
    Beermann B
    Clin Pharmacol Ther; 1982 Nov; 32(5):584-91. PubMed ID: 7127999
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacodynamics and urine pharmacokinetics of three doses of piretanide.
    Meyer BH; Müller FO; Grigoleit HG; Dagrosa EE
    Eur J Clin Pharmacol; 1983; 25(6):783-5. PubMed ID: 6662177
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Acute hypoproteinemic fluid overload: its determinants, distribution, and treatment with concentrated albumin and diuretics.
    Pappova E; Bachmeier W; Crevoisier JL; Kollar J; Kollar M; Tobler P; Zahler HW; Zaugg D; Lundsgaard-Hansen P
    Vox Sang; 1977; 33(5):307-17. PubMed ID: 919420
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Demeclocycline therapy for resistant oedema in advanced cardiac failure.
    Bonser RS; Ghose RR
    Postgrad Med J; 1980 Feb; 56(652):121-3. PubMed ID: 6771750
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Total body potassium in long-term frusemide therapy: is potassium supplementation necessary?
    Dargie HJ; Boddy K; Kennedy AC; King PC; Read PR; Ward DM
    Br Med J; 1974 Nov; 4(5940):316-9. PubMed ID: 4215534
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Observations of renal function in patients undergoing therapeutic diuresis with frusemide.
    Jewkes RF; Burki N; Guz A
    Clin Sci; 1970 Apr; 38(4):439-49. PubMed ID: 5428807
    [No Abstract]   [Full Text] [Related]  

  • 98. Comparative studies on the diuretic and biochemical effects of prednisone and spironolactone in hepatic cirrhosis.
    Lintrup J; Friis T; Nissen NI
    Acta Med Scand; 1966 Jan; 179(1):13-21. PubMed ID: 5904454
    [No Abstract]   [Full Text] [Related]  

  • 99. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    Jolobe OM
    J Hepatol; 1993 Sep; 19(2):321-2. PubMed ID: 8301072
    [No Abstract]   [Full Text] [Related]  

  • 100. Diuretic escape and rebound oedema in renal allograft recipients.
    Chan MK; Sweny P; Varghese Z; Fernando ON; Moorhead JF
    Br Med J; 1979 Jun; 1(6178):1604-5. PubMed ID: 380750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.